Confirmed Control Announced Deal verified CPGMicrobiome SupplementsProbioticsProbiotics / Microbiome Supplements
Microbiome Labs acquired by Novozymes
Novozymes agreed to acquire Microbiome Labs, an US probiotics / microbiome supplements brand on Jan 6, 2021. The transaction value is shown as USD 125m. The current comp implies EV / revenue of 3.1x. Public sources confirm the deal; valuation inputs may include estimates where transaction materials do not disclose the full economics.
Transaction summary
- Target
- Microbiome Labs
- Acquirer
- Novozymes
- Seller
- -
- Announced
- 2021-01-06
- Geography
- United States
- Tags
- CPGMicrobiome SupplementsProbioticsProbiotics / Microbiome Supplements
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-19
- Latest update
- 2026-06-19
Value and multiples
Price / value
$125M
Consideration | USD
Basis: Public source
EV / revenue
3.1x
unknown
Basis: FundComb estimate
EV / EBITDA
6x
Basis: FundComb estimate
Basis
- USD 125m consideration is treated as publicly disclosed or derived directly from public source data.
- EV / revenue is shown as 3.1x based on the available comp inputs.
- Revenue and multiple inputs are not fully disclosed in public transaction materials reviewed; treat the multiple as an estimate.
- EV / EBITDA is shown as 6x based on the available comp inputs.
Source summary
No public source summary has been published for this transaction yet.